HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department.

AbstractSTUDY OBJECTIVE:
To assess the safety and efficacy of rectal prochlorperazine in the treatment of acute migraines.
DESIGN:
Randomized, double-blinded, placebo-controlled study.
SETTING:
Emergency department of an inner-city university hospital.
PARTICIPANTS:
ED patients with documented diagnosis of migraines.
INTERVENTIONS:
Vital signs and level of alertness were monitored immediately before drug administration and 120 minutes after dosing. Pain intensity and adverse events were monitored immediately before drug administration and at 30, 60, and 120 minutes after dosing.
RESULTS:
A positive outcome was defined as a pain score less than or equal to 5 on a 10-point scale or a 50% reduction in pain intensity from baseline at 120 minutes after dosing. All patients treated with prochlorperazine suppositories experienced a positive treatment outcome; only 50% of patients treated with placebo experienced a positive result at 120 minutes after dosing (P = .016). Pain intensity scores were significantly lower in the prochlorperazine group at 120 minutes (P = .018). There were no adverse reactions in either group, and there were no significant differences in vital signs or levels of alertness between groups. Patients who failed therapy were given rescue medication 120 minutes after dosing.
CONCLUSION:
Prochlorperazine administered as a 25-mg rectal suppository provides excellent pain relief within 2 hours in patients with acute migraines.
AuthorsE B Jones, E R Gonzalez, J G Boggs, J A Grillo, R K Elswick Jr
JournalAnnals of emergency medicine (Ann Emerg Med) Vol. 24 Issue 2 Pg. 237-41 (Aug 1994) ISSN: 0196-0644 [Print] United States
PMID8037389 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Prochlorperazine
Topics
  • Acute Disease
  • Administration, Rectal
  • Adult
  • Double-Blind Method
  • Emergency Service, Hospital
  • Female
  • Humans
  • Male
  • Migraine Disorders (drug therapy)
  • Pain Measurement
  • Pilot Projects
  • Prochlorperazine (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: